Sircar R, Nichtenhauser R, Ieni J R, Zukin S R
J Pharmacol Exp Ther. 1986 May;237(2):681-8.
The binding specificity of (+)-[3H]N-allylnormetazocine, the dextrorotatory isomer of the prototypical sigma opiate SKF10,047, was determined in rat and mouse brain and the neuroanatomical distribution of its binding sites elucidated by quantitative autoradiography in sections of rat brain. Computer-assisted Scatchard analysis revealed an apparent two-site fit of the binding data in both species and in all rat brain regions examined. In whole rat brain, the Kd values were 3.6 and 153 nM and the maximum binding values were 40 fmol and 1.6 pmol/mg of protein for the apparent high- and low-affinity binding sites, respectively. (+)-SKF10,047, haloperidol and pentazocine were among the most potent inhibitors of 7 nM (+)-[3H]SKF10,047 binding to the higher affinity sites; rank orders of ligand potencies at these sites differ sharply from those that have been reported for the [3H]phencyclidine (PCP) site, or for eliciting PCP-like or SKF10,047-like behaviors. By contrast, rank orders of potency of sigma opiods, PCP derivatives and dioxolanes for displacement of 100 nM (+)-[3H]SKF10,047 from the more numerous lower affinity sites in the presence of 100 nM haloperidol agreed closely with their potencies in the [3H]PCP binding assay as well as their potencies in exerting PCP- or SKF10,047-like behavioral effects. In order to compare directly the anatomical localizations of PCP and (+)-SKF10,047 binding sites, quantitative light microscopy autoradiography utilizing tritium-labeled PCP and (+)-SKF10,047 was carried out in rat brain sections. (+)-[3H]SKF10,047 binding was observed to follow the regional pattern of [3H]PCP binding but also to bind in other regions not associated with PCP receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
原代σ阿片样物质SKF10,047的右旋异构体(+)-[3H]N-烯丙基去甲佐辛的结合特异性在大鼠和小鼠脑中进行了测定,其结合位点的神经解剖分布通过大鼠脑切片的定量放射自显影得以阐明。计算机辅助的Scatchard分析显示,在这两个物种以及所有检测的大鼠脑区中,结合数据呈现出明显的双位点拟合。在大鼠全脑中,表观高亲和力和低亲和力结合位点的Kd值分别为3.6和153 nM,最大结合值分别为40 fmol和1.6 pmol/mg蛋白质。(+)-SKF10,047、氟哌啶醇和喷他佐辛是7 nM(+)-[3H]SKF10,047与高亲和力位点结合的最有效抑制剂;这些位点上配体效力的排序与已报道的[3H]苯环己哌啶(PCP)位点或引发PCP样或SKF10,047样行为的排序有很大差异。相比之下,在100 nM氟哌啶醇存在的情况下,σ阿片样物质、PCP衍生物和二氧戊环从数量更多的低亲和力位点置换100 nM(+)-[3H]SKF10,047的效力排序与它们在[3H]PCP结合试验中的效力以及它们产生PCP样或SKF10,047样行为效应的效力密切一致。为了直接比较PCP和(+)-SKF10,047结合位点的解剖定位,利用氚标记的PCP和(+)-SKF10,047在大鼠脑切片上进行了定量光学显微镜放射自显影。观察到(+)-[3H]SKF10,047的结合遵循[3H]PCP结合的区域模式,但也在与PCP受体无关的其他区域结合。(摘要截短于250字)